Last reviewed · How we verify

NCT03806972: CRF

Short and Long Term Prognosis of Patients Admitted to the ED With Acute Heart Failure

Recruiting now Last updated 22 July 2025
What this trial tests

trial in Acute Heart Failure in 3,000 participants. Currently enrolling.

Timeline
1 June 2009
Primary endpoint
1 December 2030
1 December 2030

Quick facts

Lead sponsorUniversity of Monastir
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment3,000
Start date1 June 2009
Primary completion1 December 2030
Estimated completion1 December 2030
Sites1 location across Tunisia

Conditions studied

Sponsor

University of Monastir

Who can join

Adults 18 to 80, any sex, with Acute Heart Failure. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Heart failure (HF) is the leading cause of hospitalization ,rehospitalization and mortality for adults over 65 years of age. This study aimed to assess mortality, and hospitalization rates at 30 days and one year after dicharge of patients with heart failure (HF) with reduced ejection fraction (HFrEF) compared to HF with preserved ejection fraction (HFpEF).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Acute Heart Failure

Currently open trials in the same condition.

Other University of Monastir trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03806972.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing